Pesquisar
10X Genomics Inc
TXGAdicionar à lista de desejos
34.770USD
+2.640+8.22%
Fechamento 06/18, 16:00（ET）Cotações atrasadas em 15 min
4.08BValor de mercado
PerdaP/L TTM
Mais detalhes de 10X Genomics Inc Empresa
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Informações de 10X Genomics Inc
Código da empresaTXG
Nome da Empresa10X Genomics Inc
Data de listagemSep 12, 2019
CEOSaxonov (Serge Wilson)
Número de funcionários1306
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 12
Endereço6230 Stoneridge Mall Road
CidadePLEASANTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94588
Telefone19254017300
Sitehttps://www.10xgenomics.com/
Código da empresaTXG
Data de listagemSep 12, 2019
CEOSaxonov (Serge Wilson)
Executivos da empresa 10X Genomics Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.13M
-2.55%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
Dr. Shehnaaz Suliman, M.D.
Dr. Shehnaaz Suliman, M.D.
Independent Director
Independent Director
37.45K
+23.58%
Mr. Alan V. Mateo
Mr. Alan V. Mateo
Independent Director
Independent Director
--
--
Dr. Sarah A. Teichmann
Dr. Sarah A. Teichmann
Independent Director
Independent Director
--
--
Mr. Adam S. Taich
Mr. Adam S. Taich
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.13M
-2.55%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
378.44K
+2.33%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
105.23K
-11.02%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
Perguntas frequentes
Quem são os cinco principais acionistas de 10X Genomics Inc?
Os cinco principais acionistas de 10X Genomics Inc são: Mr. Serge Wilson Saxonov, Ph.D.
Quantas instituições possuem ações da 10X Genomics Inc (TXG)?
Em 2026Q1, 726 instituições possuíam ações da 10X Genomics Inc, com valor de mercado aproximado de 140.84M, representando 118.45% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -2946322.00.
Qual é a maior fonte de receita da 10X Genomics Inc?
Em 2026Q1, o segmento de negócios Consumables gerou a maior receita para 10X Genomics Inc, totalizando 507.18M e representando 78.90% da receita total.
